ANIK

Anika Therapeutics (ANIK)

Anika Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANIK

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/12	06 : 07	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/12	06 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/08	05 : 01	GlobeNewswire Inc.	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/06	05 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/06	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/06	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/06	05 : 07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/06	05 : 06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ANIK	Anika Therapeutics Inc
2024/06/06	05 : 06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/31	05 : 31	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/29	06 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/29	05 : 05	GlobeNewswire Inc.	Anika Enters into Cooperation Agreement with Caligan Partners	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/09	06 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/09	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/09	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/09	05 : 08	GlobeNewswire Inc.	Anika Announces CFO Transition	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/09	05 : 05	GlobeNewswire Inc.	Anika Reports First Quarter 2024 Financial Results	NASDAQ:ANIK	Anika Therapeutics Inc
2024/05/04	05 : 01	GlobeNewswire Inc.	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ANIK	Anika Therapeutics Inc
2024/04/19	05 : 01	GlobeNewswire Inc.	Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024	NASDAQ:ANIK	Anika Therapeutics Inc
2024/04/02	21 : 00	GlobeNewswire Inc.	Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:ANIK	Anika Therapeutics Inc
2024/03/14	05 : 05	GlobeNewswire Inc.	Anika Reports Fourth Quarter and Year-End 2023 Financial Results	NASDAQ:ANIK	Anika Therapeutics Inc
2024/03/13	20 : 03	IH Market News	Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb	NASDAQ:ANIK	Anika Therapeutics Inc
2024/03/09	06 : 01	GlobeNewswire Inc.	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ANIK	Anika Therapeutics Inc
2024/03/07	09 : 30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ANIK	Anika Therapeutics Inc
2024/02/28	06 : 01	GlobeNewswire Inc.	Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024	NASDAQ:ANIK	Anika Therapeutics Inc
2024/02/26	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIK	Anika Therapeutics Inc
2024/02/13	23 : 00	GlobeNewswire Inc.	Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting	NASDAQ:ANIK	Anika Therapeutics Inc
2024/02/10	01 : 09	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ANIK	Anika Therapeutics Inc
2024/01/25	04 : 27	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ANIK	Anika Therapeutics Inc
2024/01/22	23 : 29	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:ANIK	Anika Therapeutics Inc